Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by TADAMASA NAKAZAWA
Metabolic Studies on CS-359, a New .BETA.-adrenergic Blocking Agent. I. Isolation and Identification of the Urinary Metabolites of CS-359.
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Related publications
Antihypertensive and Hemodynamic Properties of the New Beta Adrenergic Blocking Agent Timolol
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Hemodynamic Effects of Tilisolol, a New .BETA.-adrenergic Blocking Agent With Vasodilating Property, and Doxazosin, a New .ALPHA.-adrenergic Blocking Agent, in Essential Hypertension.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
(359) Georgia
Effects of a New Psychotropic Agent, CS-430, on the Central Nervous System of Experimental Animals.
Folia Pharmacologica Japonica
Pharmacology
Aircraft Identification Based on CS and SVM Techniques
International Journal of Digital Content Technology and its Applications
Studies on the New Metabolic Pathway of Anthranilic Acid in the Rat. I. Isolation and Urinary Excretion of Anthranilamide as a New Metabolite of Anthranilic Acid
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
The Action of Sympathomimetic Amines and a New Beta-Adrenergic Blocking Agent (4-(2-Hydroxy-3-Isopropylaminopropoxy)-Indole) on the Isolated Trachea of Guinea Pigs
The Japanese Journal of Pharmacology
Beta-Adrenergic Blocking Drugs and Thyroid Function.
BMJ
Regeneration of Used Frying Palm Oil With Coffee Silverskin (CS), CS Ash (CSA) and Nanoparticles of CS (NCS)
Journal of Oleo Science
Medicine
Chemistry
Chemical Engineering
